References
Matta WH, Stabile I, Shaw RW,et al.: Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist buserelin. Fertil Steril 1988;49:1083–1085
Schlaff WD, Zerhouni EA, Huth JA,et al.: A placebo controlled trial of depot GnRH-analogue (Leuprolide) in the treatment of uterine leiomyomata. Obstet Gynecol 1989;74: 856–862
Carr BR, Marshburn PB, Weatherall PT,et al.: An evaluation of GnRH-analogue and medroxyprogesterone acetate on uterine volume by magnetic resonance imaging: A prospective, randomized, double-blind, placebo-controlled crossover trial. J Clin Endocrinol Metab 1993;76:1217–1223
Letterie GS, Coddington CC, Winkel CA,et al.: Efficacy of a GnRH-agonist in the treatment of uterine leiomyomata: Long-term followup. Fertil Steril 1989;51:951–956
Pirhoren JP, Vuento MH, Makinen JI,et al.: Long term effects of hormone replacement therapy on uterus and uterine circulation. Am J Obstet Gynecol 1993;168:620–623
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spong, C.Y., Sinow, R., Renslo, R. et al. Induced hypoestrogenism increases the arterial resistance index of leiomyomata without affecting uterine or carotid arteries. J Assist Reprod Genet 12, 338–341 (1995). https://doi.org/10.1007/BF02213716
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02213716